What is included in the long-term outpatient care for lymphoblastic lymphoma?

1. Precursor lymphoid neoplasms. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th Edition. Lyon, France: IARC; 2016. Volume 2: 199-214.

2. [Guideline] National Cancer Care Network. NCCN Clinical Guidelines in Oncology: Acute Lymphoblastic Leukemia, Version 2.2016. NCCN.org. Available at https://www.nccn.org/professionals/physician_gls/pdf/all.pdf. March 12, 2018; Accessed: April 4, 2018.

3. Hoffman R, Benz EJ Jr, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 6th Ed. New York, NY: Churchill-Livingstone; 2013.

4. Liu W, Hu S, Konopleva M, Khoury JD, Kalhor N, Tang G, et al. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis. Pediatr Hematol Oncol. 2015 Nov 11. 1-13. [Medline].

5. Taylor J, Xiao W, Abdel-Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood. 2017 Jul 27. 130 (4):410-423. [Medline]. [Full Text].

6. Smock KJ, Nelson M, Tripp SR, Sanger WG, Abromowitch M, Cairo MS, et al. Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2008 Oct. 51(4):489-94. [Medline]. [Full Text].

7. [Guideline] Hoelzer D, Bassan R, Dombret H, Fielding A, Ribera JM, Buske C, et al. Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016 Sep. 27 (suppl 5):v69-v82. [Medline]. [Full Text].

8. Ribeiro KB, Buffler PA, Metayer C. Socioeconomic status and childhood acute lymphocytic leukemia incidence in São Paulo, Brazil. Int J Cancer. 2008 Oct 15. 123(8):1907-12. [Medline].

9. PDQ Pediatric Treatment Editorial Board. Childhood Non-Hodgkin Lymphoma Treatment (PDQ®). National Center for Biotechnology Information. Available at http://www.ncbi.nlm.nih.gov/books/NBK65738/#CDR0000062808__322. March 30, 2018; Accessed: April 6, 2018.

10. Jin X, Zhao HF, Yu Y, Zhao DD, Yang HL, Wang XF, et al. Analysis of clinical characteristics and prognostic factors of primary mediastinal T-cell lymphoblastic lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Mar. 21(2):377-82. [Medline].

11. Thomas DA, O'Brien S, Cortes J, Giles FJ, Faderl S, Verstovsek S, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood. 2004 Sep 15. 104(6):1624-30. [Medline].

12. Magrath IT. Management of high-grade lymphomas. Oncology (Williston Park). 1998 Oct. 12(10 Suppl 8):40-8. [Medline].

13. Digiuseppe JA. Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy. Clin Lab Med. 2007 Sep. 27(3):533-49, vi. [Medline].

14. Aoki Y, Miyawaki R, Imai K, Takagi M, Kajiwara M, Ishiwata Y, et al. Haploidentical Bone Marrow Transplantation With Clofarabine and Busulfan Conditioning for a Child With Multiple Recurrent Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2015 Oct 29. [Medline].

15. Kelemen K, Holden J, Johnson LJ, Davion S, Robetorye RS. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement. Cytometry B Clin Cytom. 2015 Oct 30. [Medline].

16. Burmeister T, Molkentin M, Schwartz S, Gökbuget N, Hoelzer D, Thiel E, et al. Erroneous class switching and false VDJ recombination: Molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma. Mol Oncol. 2013 Apr 25. [Medline].

17. Sullivan-Chang L, O'Donnell RT, Tuscano JM. Targeting CD22 in B-cell Malignancies: Current Status and Clinical Outlook. BioDrugs. 2013 May 22. [Medline].

18. Bailey LC, Lange BJ, Rheingold SR, Bunin NJ. Bone-marrow relapse in paediatric acute lymphoblastic leukaemia. Lancet Oncol. 2008 Sep. 9(9):873-83. [Medline].

19. Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017 Mar 2. 129 (9):1113-1123. [Medline]. [Full Text].

20. Papayannidis C, DeAngelo DJ, Stock W, Huang B, Shaik MN, Cesari R, et al. A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Blood Cancer J. 2015 Sep 25. 5:e350. [Medline]. [Full Text].

21. Knoechel B, Bhatt A, Pan L, Pedamallu CS, Severson E, Gutierrez A, et al. Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case. Cold Spring Harb Mol Case Stud. 2015 Oct. 1 (1):a000539. [Medline]. [Full Text].

Joseph M Tuscano, MD Associate Chief, Department of Hematology/Oncology/Internal Medicine, Veterans Administration Northern California System of Clinics; Professor, Department of Internal Medicine, Division of Hematology/Oncology, University of California at Davis School of Medicine

Joseph M Tuscano, MD is a member of the following medical societies: American Association of Immunologists, American College of Physicians, American Society of Hematology, American Society for Blood and Marrow Transplantation

Disclosure: Received honoraria from Genentech for speaking and teaching.

Stephen E Wang, MD Consulting Staff, Department of Internal Medicine, Division of Hematology/Oncology, Kaiser Permanente

Stephen E Wang, MD is a member of the following medical societies: American Society of Hematology

Disclosure: Nothing to disclose.

Theodore Wun, MD, FACP Professor of Medicine, Professor of Pathology and Laboratory Medicine, University of California Davis School of Medicine; Chief of Hematology/Oncology, Program Director, Veterans Affairs Northern California Health Care System; Medical Director, University of California Davis CCRC

Theodore Wun, MD, FACP is a member of the following medical societies: American Association of Blood Banks, American Society for Blood and Marrow Transplantation, American College of Physicians, American Federation for Medical Research, American Society of Hematology, SWOG

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Emmanuel C Besa, MD Professor Emeritus, Department of Medicine, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University

Emmanuel C Besa, MD is a member of the following medical societies: American Association for Cancer Education, American Society of Clinical Oncology, American College of Clinical Pharmacology, American Federation for Medical Research, American Society of Hematology, New York Academy of Sciences

Disclosure: Nothing to disclose.

Karen Seiter, MD Professor, Department of Internal Medicine, Division of Oncology/Hematology, New York Medical College

Karen Seiter, MD is a member of the following medical societies: American Association for Cancer Research, American College of Physicians, American Society of Hematology

Disclosure: Received honoraria from Novartis for speaking and teaching; Received consulting fee from Novartis for speaking and teaching; Received honoraria from Celgene for speaking and teaching.